Be ready to pounce on homebuilding stocks the next time they drop, Jim Cramer says

Be ready to pounce on homebuilding stocks the next time they drop, Jim Cramer says


CNBC’s Jim Cramer said Thursday that despite conventional wisdom, he believes investors should pick up shares of homebuilding stocks the next time they plummet.

“I believe these stocks will drop again, but when they do — and that might be on a statement from the Fed that says they’re still seeing signs of inflation — I think you’ve got to pounce,” the “Mad Money” host said. “That could be as soon as the next rate hike.”

Homebuilder sentiment fell to a two-year low on decreasing demand and rising costs in May. Mortgage rates rose sharply this week after easing over the last few weeks, as home prices also continued to rise.

But Cramer says there are bullish signs for the market suggesting that despite the Federal Reserve getting ready to tighten the economy, homebuilding stocks might go against the tide and be attractive assets for investors’ portfolios.

He pointed out that the pandemic has changed the homebuilding industry’s landscape, leaving downtown offices empty because of work-from-home, plumping potential buyers’ bank accounts and driving a baby boom that could mean more business for homebuilding companies.

In addition, skyrocketing rent prices have meant some people invested in homes rather than signing a lease, while constrained supplies of houses have kept properties from depreciating in value and led to bidding wars between potential buyers, he said.

“We’ll get more downgrades and maybe even some estimate cuts, but when they come I’m going to go out on a limb right here and I’m going to say the time is right to buy the homebuilders,” Cramer said.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More